Associate Global Project Lead

The position

As an Associate Global Project Lead at Novo Nordisk, you will : Drive the lifecycle management of in-market and pipeline assets, focusing on multiple workstreams related to oral formulation changes. Manage global change management plans related to manufacturing and packaging, ensuring seamless execution across the global supply chain. Take end-to-end ownership of various workstreams of integrated solutions for the treatment of diabetes. Lead world-class Loss of Exclusivity (LoE) management, including developing strategies and frameworks for planning and execution in different market archetypes. Analyze situations and chart future scenarios to support decision-making for the global project team and semaglutide portfolio strategies. Prepare and deliver communication for key decision-making governance bodies, such as GPT, PDCouncil, and DPPComm. Collaborate in developing the Product Development Plan (PDP) on an ongoing basis. Qualifications To be successful in this role, we are looking for someone with the following qualifications : 10+ years of overall experience in leading commercial pharma projects / pharma brand management Strong strategic and analytical capabilities, with demonstrated experience in analyzing complex data-sets, collecting data, effectively synthesizing the analytics / data to form a complete, cohesive picture Strong experience with project management Technical skills : MS PowerPoint, MS Excel (VBA, pivot etc.) and MS Word are a must About the department The Commercial GBS unit is responsible for driving deliverables for multiple Senior Vice President (SVP) and Corporate Vice President (CVP) areas, including Global Public Affairs and Sustainability (GPAS), Patient Access, Marketing, Commercial Planning, and Content hub. Our team is dedicated to creating innovative market development and communication efforts. We are located at our headquarters in Denmark, where we have a fast-paced and dynamic atmosphere. Working at Novo Nordisk Novo Nordisk is a leading global healthcare company with a -year legacy of driving change to defeat serious chronic diseases. Building on our strong legacy within diabetes, we are growing massively and expanding our commitment, reaching millions around the world and impacting more than 40 million patient lives daily. All of this has made us one of the 20 most valuable companies in the world by market cap. Our success relies on the joint potential and collaboration of our more than 63, employees around the world. We recognize the importance of the unique skills and perspectives our people bring to the table, and we work continuously.